Redasoft, United States Biological Sign Distribution Agreement for Visual Cloning Software.

(PRWEB) January 9, 2003

        

            Redasoft, United States Biological Sign Distribution Agreement for

            Visual Cloning Software.

        

         Boston, MA - January 7, 2003 - United States Biological, a leading supplier of biochemicals, biologicals, enzymes and antibodies, and Redasoft, a global provider of drug discovery productivity enhancement software for the life science research community today announced an agreement for the distribution of Redasoft's desktop software product, Visual Cloning.

        

        

            "The United States biotechnology industry is poised to continue to grow rapidly over the next decade," said Warren Shore, United States Biological's President and Chief Executive Officer. "Genomics and Proteomics will continue to place the US Biotechnology Industry in one of the highest sustained growth industries. The rapid growth of online-based software supporting scientific discovery is becoming a top priority for our company and we are pleased to be able to offer such a well-known product to our customers, who represent virtually every research lab in the US."

        

        

            "Life scientists today need both wet lab supplies and corresponding software to be successful in their research," said Danny Reda, Redasoft's President and Chief Executive Officer. "We are therefore extremely pleased to announce this distribution partnership with United States Biological whose track record of success and reputation for quality are well established."

        

        

            Redasoft Visual Cloning is an industry leading software suite that enables increased efficiency and productivity in drug discovery research. Key features of the software include exceptional graphics, extensive web integration, advanced restriction analysis, open reading frames search, primer design, a sequence viewer, subsequence search, and an intuitive user interface.

        

        

            About United States Biological

        

        

            Based in the Boston area, United States Biological is a world-wide supplier of over 30,000 biochemicals, biologicals, enzymes and antibodies used in research and development. US Biological is well known for supplying molecular biology grade products such as antibiotics, antibodies, biochemicals, carbohydrates, cell culture media, enzymes, peptides, human & animal sera and BioGene kits for Apoptosis, ELISA and Molecular Biology assays. Additional information about United States Biological can be found at http://www.usbio.net/.

        

        

         About Redasoft

        

            

            Based in Toronto, Canada, Redasoft is a global provider of drug

            discovery productivity enhancement software for the life science

            research community. Founded in 1997, Redasoft’s mission is to be an

            enabling solutions provider of intuitive, easy to use integrating

            software and services for drug discovery research. Redasoft's

            software empowers life science researchers to visualize genetic

            data, analyze biomolecules, and develop experiment strategies to

            learn more about the fundamental building blocks of life. Additional

            information about Redasoft can be found at

            http://www.redasoft.com.

        

        

        

            Contact

        

        

            Kristina Lundstrom, United States Biological, kris@usbio.net

        

        

            Evan Carmichael, Redasoft, ecarmichael@redasoft.com

        

    


Contact Information
Andrew Howitt
Redasoft



Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy